Gamma Knife Risks and Side Effects: Acute and Delayed, Named Honestly

The risks of Gamma Knife fall into two groups: acute effects in the first hours to weeks, which are usually mild and temporary, and delayed effects over months to years, of which radiation necrosis (roughly 5 to 25%) is the most important. It delivers a high dose of radiation to the brain, so it is not free of risk despite being non-invasive, but serious harm is uncommon and the whole plan is built to keep the dose to healthy tissue low¹.

When I was weighing up Gamma Knife for my acoustic neuroma, the leaflets I was handed skated over this part. They said “minimal side effects” and moved on, which left me imagining the worst in the gaps. What actually helped was someone naming each risk plainly, telling me roughly how likely it was, and separating the things that would probably annoy me for a fortnight from the one or two that genuinely mattered. That is what I have tried to set out here. For the wider picture of the treatment, start with the pillar on Gamma Knife radiosurgery, and for the calm version of the safety question overall, see is Gamma Knife safe.

What are the acute side effects of Gamma Knife?

The acute side effects, in the first hours to about two months, are usually mild and temporary: fatigue, headache, nausea, temporary hair thinning near the treated area, and pin-site soreness if you had a frame. None of these needs treating in most people, and most settle on their own². The ones worth expecting are:

• Fatigue: the most reliably underestimated one. It can last days to a few weeks and is easy to mistake for the emotional toll of the whole thing.
• Headache: common in the first hours to days, usually mild and eased with simple painkillers.
• Nausea: less common, sometimes linked to the position of the target, and usually short-lived.
• Hair thinning: only where enough dose passed through the scalp, so it is patchy rather than general, with regrowth over about 2 to 3 months.
• Pin-site soreness: frame-based treatment only, and uncommon; the four points where the frame was pinned can feel bruised for a few days.

The fatigue caught me out. Nobody had flagged it, so when I felt flattened for the best part of two weeks I assumed something had gone wrong, when in fact it was ordinary. If that is where you are, I wrote it up honestly in fatigue after Gamma Knife. The pin sites, for what it is worth, were the least of it: I go into what the frame actually felt like in what the Gamma Knife frame feels like.

What is radiation necrosis and how common is it?

Radiation necrosis is the most important delayed effect of Gamma Knife: a reaction of treated and nearby tissue to the radiation, appearing months after treatment, reported in roughly 5 to 25% of cases. The risk is driven mainly by the size of the target (over about 20 mm) and the dose delivered, and it is often manageable, for example with corticosteroids or a drug called bevacizumab¹. It does not always cause symptoms; sometimes it shows up only as a change on a follow-up scan.

The point that took me longest to absorb is that necrosis is not the same as the treatment failing. It is the tissue reacting to a dose that reached its target, not the tumour regrowing. On a scan it can look worrying, and telling it apart from a recurrence sometimes needs extra imaging, but it is a known, treatable part of how radiosurgery works rather than a disaster. I set out what I learned about it, without the panic, in radiation necrosis, what I learned.

What is oedema and how is it managed?

Brain swelling, called oedema, is a common delayed effect and is managed with corticosteroids such as dexamethasone. As the treated tissue reacts, some swelling around it is expected, and where it causes symptoms it is usually controlled well with a short course of steroids¹. It overlaps with radiation necrosis, and the two are often talked about together because they are managed in similar ways.

For me this was reassuring to hear in advance, because a symptom that arrives weeks after you thought you were done can feel like a setback when it is actually anticipated and treatable. Understanding the slow timeline of radiosurgery helped, and that is covered in Gamma Knife results and follow-up.

Can Gamma Knife affect the cranial nerves and hearing?

Yes, targets that sit near the cranial nerves can affect those nerves, most often as hearing change for treatments at the skull base such as acoustic neuroma. For acoustic neuroma the trade-off is well studied: 5-year tumour control is roughly 90 to 99% at a margin dose most commonly 12 to 13 Gy, while hearing preservation varies widely, around 40 to 80%, and tends to decline over the years. Facial-nerve preservation is high, about 95 to 100% at 5 years³. These numbers depend heavily on tumour size, your baseline hearing and how long you are followed, so no single figure fits everyone.

My own treatment was for an acoustic neuroma, and the hearing question was the one I cared about most, more than the tumour itself. It is worth reading the detail rather than a headline number: see hearing after Gamma Knife for acoustic neuroma and the wider Gamma Knife for acoustic neuroma.

Can Gamma Knife affect hormones (hypopituitarism)?

Gamma Knife can affect hormone levels when the target is the pituitary gland or sits near it, a delayed effect called hypopituitarism, reported across a wide range of 0 to 70%. The variation is genuine: it depends on the size and location of the target and, importantly, on how long people are followed, because the effect often appears gradually over years rather than at once⁴. That is why pituitary and skull-base treatments come with ongoing endocrine follow-up, so that any hormone that starts to run low can be replaced.

If a pituitary target is what brought you here, the balance of tumour control (over 90%) against this hormonal risk is set out in Gamma Knife for pituitary adenoma.

How rare is a second tumour after Gamma Knife?

A radiation-caused second tumour is very rare after Gamma Knife, on the order of well under 1% over many years of follow-up, and is treated as clinically negligible against the benefit of controlling the target. It is the question people fear most and it comes up in nearly every consultation, so it deserves a plain answer rather than silence, but the numbers put it in proportion³. The dose is focused and the volume of healthy tissue exposed is small, which is part of why the long-term risk stays this low.

I asked about this myself, half expecting to be brushed off, and instead got a straight figure that made the risk feel manageable. Being told the real number was far more reassuring than being told not to worry. For more of the questions worth putting to your own team, see questions to ask before Gamma Knife, and for the common misconceptions untangled, Gamma Knife myths and facts.

How do the risks of Gamma Knife compare with surgery?

Gamma Knife avoids the risks that come with an incision, a general anaesthetic and a hospital stay, but it carries its own delayed radiation risks and works slowly, so it is not automatically the safer choice for every target. Open surgery can offer rapid relief of pressure and a tissue diagnosis that radiosurgery cannot, which is why the team weighs them against each other rather than defaulting to the non-invasive option. Single-session radiosurgery typically suits targets around 3 to 3.5 cm or smaller; larger ones are often better served by surgery or by splitting the dose³.

I had assumed the no-incision option must be the lower-risk one across the board, and it took the team spelling out the trade-offs to see that “lower risk” depends entirely on the target. The comparison is worth reading in full in Gamma Knife versus surgery, and if watching rather than treating is on the table, in watch and wait versus Gamma Knife.